log 2 transformed, and genes were considered expressed when log 2 TPM values displayed a mean >1·5 for a given gene, when gene TPM values were averaged for each genotype at each age (resulting in a total of 18,562 genes expressed).
Weighted gene co-expression network analyses (WGCNAs) were performed as described in Matarin et al., (2015) , using the recommended parameters from the original analysis developers (Zhang and Horvath, 2005; Horvath et al., 2006; Oldham et al., 2006; Langfelder and Horvath, 2008) . R code and tutorials available from: https://horvath.genetics.ucla.edu/html/CoexpressionNetwork/Rpackages/WGCNA/ind ex.html). Co-expression networks were built using the WGCNA package in R. Genes with variable expression patterns (coefficient of variation >5% for wild-type, amyloid and tau mice) from log 2 TPM values were selected for network analyses resulting in 13,536 genes for network analyses. The module of genes with the highest significant correlation of the module eigengene with amyloid or tau pathological features was selected for analysis (amyloid, correlation 0·94, p = 3e -41 ; tau, correlation 0·82, p = 4e -12 ). The gene module with the highest correlation to both amyloid and tau pathological features contained genes from the innate immune system. The topological overlap measure (TOM) connectivity values were used to plot the network diagrams (TOM > 0·39 for amyloid-associated module, and TOM > 0·36 for tauassociated module, to plot a similar number of genes, approximately the top 150 genes with the highest connections per module). Hub genes were considered to be those with at least 15 connections to other genes as Matarin et al., (2015) , and Miller et al., (2010) .
Human sample co-expression network construction and annotation
Co-expression networks were generated from RNA-seq based gene expression profiling of 635 pre-frontal cortex samples from the ROS/MAP project (Bennett et al., 2012a; Bennett et al., 2012b; De Jager et al., 2018) . The cognitive decline reported in the original studies cited above was used as a covariate to construct four networks: all samples network, not AD, probable AD and AD. WGCNA (Langfelder and Horvath, 2008) was used with an optimization for constructing more biologically meaningful co-expression networks (Botia et al., 2017) . Gene expression was log 2 transformed previous to any data analysis task. Then batch effects were corrected using ComBAT (Johnson et al., 2007) , unknown hidden effect covariates with SVA were obtained (Leek and Storey, 2007) , and the residuals obtained were used by regressing the gene expression with SVA covariates, age and gender. Then the network modules were annotated for enrichment of Gene Ontology, REACTOME (Fabregat et al., 2018) , and KEGG (Kanehisa et al., 2016) pathways using gProfileR (Reimand et al., 2007) .
Colocalization with monocyte eQTL datasets
Coloc (version 3.1, see below for Software and algorithms) was applied to test for colocalization between AD loci surrounding the four novel risk genes (OAS1, LAPTM5, ITGAM, and LILRB4) and eQTLs (Giambartolomei et al., 2014) . While no microglial eQTL datasets exist to date, eQTL analyses have been performed using monocytes and iPSC-derived macrophages (at rest and stimulated with various immunostimulants, such as IFN-γ) (Kim-Hellmuth et al., 2017; Alasoo et al., 2018) .
Coloc was run using default parameters and priors on all SNPs that: 1) had eQTLs tagging one of the four novel genes (this included all tested SNP-gene associations, including non-significant eQTLs); and 2) had overlapping SNPs in the AD GWAS.
All loci were excluded for which PP3 + PP4 < 0·8, to exclude loci which were underpowered to detect colocalization. Loci with PP4/PP3 ≥ 2 were considered colocalized due to a single shared causal variant (PP4), as opposed to two distinct causal variants (PP3).
Software and algorithms
Mouseac, this paper and Matarin et al. (2015) : www.mouseac.org WGCNA (Langfelder and Horvath, 2008 ROS/MAP (Bennett et al., 2012a; Bennett et al., 2012b; De Jager et al., 2018) :
https://www.synapse.org/#!Synapse:syn3219045 (accessed September 2018) i-CisTarget (Imrichova et al., 2015) : https://gbiomed.kuleuven.be/apps/lcb/i-cisTarget (accessed September 2018) GTEx V6 gene expression (Consortium GT, 2015) : https://gtexportal.org/home (accessed September 2018)
Coexp (Botia et al., 2017) Matarin et al., (2015) , where the amyloid and tau pathology were assessed by immunohistochemistry, and microarrays were performed to identify gene expression changes and co-expression networks expressed by microglia associated with pathology. Parallel cohorts of mice from the APP/PSEN1 lines (represented by the dashed arrow) were then used to count the increase in microglial number and activity in the CA1 of the hippocampus, alongside electrophysiological deficits in synaptic plasticity of acute hippocampal slices and mild changes to behaviour (Medawar et al., 2019) . For this new study, we performed RNA-seq using the total RNA from the hippocampus of the exact same mice used for study by Matarin et al., (2015) , and using gene co-expression network analyses we identified a higher resolution network expressed by amyloid-responsive or tau-responsive microglia. In this study we also statistically compare the genes present in the mouse microglial networks using human gene-level sequence variants associated with Alzheimer's disease as assessed in the IGAP GWAS (Kunkle et al., 2019) .
GWAS hit!
Predicted gene! Supplementary Figure 2 Recombination rate (cM/Mb) The SNP positions are provided from Build 37, Assembly Hg19, and illustrated using LocusZoom software. The left y-axis gives the significance of each single SNP associated with Alzheimer's disease from IGAP, and the right y-axis gives the recombination rate along the gene where a higher recombination rate indicates greater independence between SNPs. The SNP with the most significant p-value for LAPTM5 was rs7549164, and for OAS1 was rs4766676 according to Kunkle et al., (2019) , but not available in the data used by the LocusZoom software for LD estimation. Dashed line illustrates p-value = 0.05. The SNP positions are provided from Build 37, Assembly Hg19, and illustrated using LocusZoom software. The left y-axis gives the significance of each single SNP associated with Alzheimer's disease from IGAP, and the right y-axis gives the recombination rate along the gene where a higher recombination rate indicates greater independence between SNPs. The SNP with the most significant p-value within each gene is labelled, for ITGAM rs79113991, and for LILRB4 rs731170 according to Kunkle et al., (2019) . Dashed line illustrates p-value = 0.05. Figure 6 Relative expression of the orthologues of the four genes predicted to confer increased risk of Alzheimer's disease alongside the established GWAS risk gene Trem2 and a reference Aif1 in APP/PSEN1 mice.
Supplementary
(A) The expression of the genes in the homozygous APP/PSEN1 mice is shown relative to age-matched wild-type mice. The dotted red line represents the average expression of 1,584 genes in the innate immune network ( Supplementary Table 1 ) in homozygous APP/PSEN1 mice relative to age-matched wild-type mice (dashed black line = 1.0). N = 3-4 homozygous APP/PSEN1 and N = 7-8 wild-type mice per age group. Data shown as mean ± SEM. Two-way ANOVA with significant main effects of genotype (p < 0.0001), age (p < 0.0001) and significant interaction (p < 0.0001).
Dunnett's multiple comparisons tests were used to test pairwise significance between each gene and the average relative expression of all genes in the innate immune network: Oas1a and Trem2 were significant at 8-and 18-months of age compared to average relative expression of all genes in network; **** p<0.0001. Laptm5 and Lilra5 were significant only at 8-months of age compared to average relative expression of all genes in network; * p<0.05.
(B) The expression of the genes in the hemizygous APP/PSEN1 mice is shown relative to age-matched wild-type mice. The dotted red line represents the average expression of 1,584 genes in the innate immune network ( Supplementary Table 1 ) in hemizygous APP/PSEN1 mice relative to age-matched wild-type mice (dashed black line = 1.0). N = 4 hemizygous APP/PSEN1 and N = 7-8 wild-type mice per age group. Data shown as mean ± SEM. Two-way ANOVA with significant main effects of genotype (p < 0.0001), age (p < 0.0001) and significant interaction (p < 0.0001).
Dunnett's multiple comparisons tests were used to test pairwise significance between each gene and the average relative expression of all genes in the innate immune network: Oas1a and Trem2 were significant at 8-and 18-months of age compared to average relative expression of all genes in network; **** p<0.0001. Lilra5 was significant at 8-months of age (**** p<0.0001), and significant at 18-months of age (* p<0.05), compared to age-matched average relative expression of all genes in network. The genes LAPTM5, ITGAM, LILRB4, OAS1, TREM2, ABI3, CD33, SPI1, INPP5D, PLCG2, RIN3 and APOE were used as seeds, and for each seed gene, sequentially, the genes most connected to it were added (based on TOM values). This allows visualization of the connectivity context around specific genes that are not necessarily clustering together (i.e. they belong to different network modules), but likely crosstalk and interact. The colours indicate that the genes belong to three modules.
Annotating the modules for enrichment with Gene Ontology, REACTOME and
